background: massive ischemic stroke causes significant mortality and morbidity in stroke patients. the main treatments for massive ischemic stroke are recombinant tissue plasminogen activator (rtpa), craniotomy, and endovascular interventions. due to destructive  effects  of   bradykinin  on  the  nervous system in ischemic stroke, it seems reasonable that using noscapine as a bradykinin antago...

background: stroke is one of the most frequent causes of death and disability worldwide and has significant clinical and socioeconomic impact. hyperlipidemia and inflammation play major roles in atherothrombosis and in stroke. this study is conducted to compare the high sensitive c-reactive protein (hs-crp) levels and the lipid profile parameters between stroke patients and control group and de...

BACKGROUND Massive ischemic stroke causes significant mortality and morbidity in stroke patients. The main treatments for massive ischemic stroke are recombinant tissue plasminogen activator (rtPA), craniotomy, and endovascular interventions. Due to destructive effects of bradykinin on the nervous system in ischemic stroke, it seems reasonable that using Noscapine as a Bradykinin antagonist may...

background: stroke is a heterogeneous disease with several risk factors. high sensitivity c-reactive protein (hscrp) is a marker for cardiovascular and cerebrovascular diseases. recent studies have shown that high hscrp level is a risk factor for ischemic stroke. the objective of our study was to investigate the association of high hscrp (> 3 mg/l) levels with ischemic stroke and its subtypes i...

background:  the aim of this study was to evaluate whether higher serum levels of igf-i in the acute phase of ischemic stroke are associated with less severe strokes and better functional outcome in a period of one year follow up. methods: from october 2014 to august 2015, patients with the diagnosis of acute ischemic stroke admitted to the stroke unit of firoozgar hospital entered this prospec...

background: as yet migraine has been established as one of the risk factors for ischemic stroke. some of the factors have been assessed for the explanation of this relation. hyperhomocysteinemia is seen partly both in stroke and in migraine. this study was conducted to determine the mean plasma levels of homocysteine in ischemic stroke patients on the basis of migraine history.methods: this cro...

conclusions due to considerable inter- and intra- heterogeneity among studies performed by other centers such as differences in study project, background, and population features, determining a pharmacotherapy model based on safe implementation of treatments in stroke or sits seem advantageous. results age, time of onset, systolic blood pressure, diabetes, stroke severity, co-morbidities and pr...

background: we intended to investigate the serum magnesium impact upon the disability after ischemic stroke. methods: a total of 67 ischemic stroke patients who less than 6 hours had passed from their attacks participated in this cross sectional study. we have measured their serum magnesium level and determined its correlation with their rankin disability score (rds) in the first 72 hours (rds0...

background and purpose: the relationship between uric acid and stroke recurrence is ambiguous. some studies have explored this relationship in acute ischemic stroke but had different results. we evaluated the association of admission uric acid level with risk of stroke recurrence in patients with ischemic stroke. methods: we studied ischemic stroke patients presenting to our hospital with magne...